Correlation Between Ascletis Pharma and Rigel Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Ascletis Pharma and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascletis Pharma and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ascletis Pharma and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Ascletis Pharma and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascletis Pharma with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascletis Pharma and Rigel Pharmaceuticals.

Diversification Opportunities for Ascletis Pharma and Rigel Pharmaceuticals

0.8

Correlation Coefficient

Ascletis Pharma  Rigel Pharmaceuticals

Very poor diversification

The 3 months correlation between Ascletis and Rigel is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Ascletis Pharma and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Ascletis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascletis Pharma are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Ascletis Pharma i.e., Ascletis Pharma and Rigel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ascletis Pharma and Rigel Pharmaceuticals

Assuming the 90 days horizon Ascletis Pharma is expected to generate 3.94 times less return on investment than Rigel Pharmaceuticals. But when comparing it to its historical volatility, Ascletis Pharma is 1.83 times less risky than Rigel Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Rigel Pharmaceuticals is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  1,312  in Rigel Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  1,449  from holding Rigel Pharmaceuticals or generate 110.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	98.44%
Values	Daily Returns

Ascletis Pharma  vs.  Rigel Pharmaceuticals

Ascletis Pharma

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ascletis Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Ascletis Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Rigel Pharmaceuticals

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Rigel Pharmaceuticals are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Rigel Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ascletis Pharma and Rigel Pharmaceuticals

The main advantage of trading using opposite Ascletis Pharma and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascletis Pharma position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.

The idea behind Ascletis Pharma and Rigel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.